ASBS Board certification in surgery
- At least one year breast ultrasound experience
- Minimum procedure volume of 100 breast ultrasound exams (80 diagnostic, 20 interventional) and review of 100 mammography exams within the last 12 months
- Minimum 15 AMA Category 1 CME units in breast ultra sound. Seven of these must be obtained in the 12 months prior to submitting the application and must include hands-on training.
- Case studies for 10 patients imaged in the last 12 months submitted for review (five diagnostic and five interventional, including three core biopsies, and two cyst aspiration or fine-needle aspiration biopsies). Ultrasound-guided vacuum assisted or rotational core biopsy procedures may be submitted in place of the core biopsy procedures.
- Written exam, minimum score 85%
ACR Board certification in radiology
- Meet MQSA and ACR standards for screening and diagnostic mammography OR
- Complete residency program with three months training, appropriate fellowship or postgraduate training involving 500 ultrasound exams in a broad spectrum of uses, including breast ultrasound OR
- If completed training prior to 1982, have 10 years' experience performing and interpreting ultrasound exams OR
- In the absence of fellowship or postgraduate training, have two years of ultrasound experience with a minimum of 500 general ultrasound or 100 breast ultrasound exams (performed or supervised and interpreted).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.